Advertisement

European Journal of Epidemiology

, Volume 34, Issue 5, pp 471–481 | Cite as

Association of serum markers of oxidative stress with myocardial infarction and stroke: pooled results from four large European cohort studies

  • Yang Xuan
  • Martin Bobak
  • Ankita Anusruti
  • Eugène H. J. M. Jansen
  • Andrzej Pająk
  • Abdonas Tamosiunas
  • Kai-Uwe Saum
  • Bernd Holleczek
  • Xin Gao
  • Hermann Brenner
  • Ben SchöttkerEmail author
CARDIOVASCULAR DISEASE
  • 237 Downloads

Abstract

Oxidative stress contributes to endothelial dysfunction and is involved in the pathogenesis of myocardial infarction (MI) and stroke. However, associations of biomarkers of oxidative stress with MI and stroke have not yet been addressed in large cohort studies. A nested case–control design was applied in four population-based cohort studies from Germany, Czech Republic, Poland and Lithuania. Derivatives of reactive oxygen metabolites (d-ROMs) levels, as a proxy for the reactive oxygen species burden, and total thiol levels (TTL), as a proxy for the reductive capacity, were measured in baseline serum samples of 476 incident MI cases and 454 incident stroke cases as well as five controls per case individually matched by study center, age and sex. Statistical analyses were conducted with multi-variable adjusted conditional logistic regression models. d-ROMs levels were associated with both MI (odds ratio (OR), 1.21 [95% confidence interval (CI) 1.05–1.40] for 100 Carr units increase) and stroke (OR, 1.17 [95% CI 1.01–1.35] for 100 Carr units increase). TTL were only associated with stroke incidence (OR, 0.79 [95% CI 0.63-0.99] for quartiles 2–4 vs. quartile 1). The observed relationships were stronger with fatal than with non-fatal endpoints; association of TTL with fatal MI was statistically significant (OR, 0.69 [95% CI 0.51–0.93] for 100 μmol/L-increase). This pooled analysis of four large population-based cohorts suggests an important contribution of an imbalanced redox system to the etiology of mainly fatal MI and stroke events.

Keywords

Oxidative stress Myocardial infarction Stroke Cardiovascular disease Cohort study 

Notes

Funding

This project was funded by a grant from the German Research Foundation (Grant No. SCHO 1545/3-1) and a scholarship from the China Scholarship Council (CSC) to Yang Xuan. The CHANCES project was funded in the FP7 framework programme of DG-RESEARCH in the European Commission (Grant No. 242,244). The CHANCES project was coordinated by the Hellenic Health Foundation, Greece. Further funding sources of participating cohorts: The ESTHER study was funded by the Baden-Württemberg state Ministry of Science, Research and Arts (Stuttgart, Germany), the Federal Ministry of Education and Research (Berlin, Germany) and the Federal Ministry of Family Affairs, Senior Citizens, Women and Youth (Berlin, Germany). The HAPIEE study was funded by the Welcome Trust (064947 and 081081), the US National Institute on Ageing (R01 AG23522) and a grant from Mac Arthur Foundation. The authors are indebted to Mr. Piet Beekhof for the measurement of all oxidative stress biomarkers. We also acknowledge the work of Anne Peasey, Růžena Kubínová, Hynek Pikhart and Roman Topor-Madry in the conduct of the HAPIEE study.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

10654_2018_457_MOESM1_ESM.docx (1.7 mb)
Supplementary material 1 (DOCX 1784 kb)

References

  1. 1.
    Frostegard J. Immunity, atherosclerosis and cardiovascular disease. BMC Med. 2013;11:117.CrossRefGoogle Scholar
  2. 2.
    Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84:1381–478.CrossRefGoogle Scholar
  3. 3.
    Chen K, Keaney JF Jr. Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease. Curr Atheroscler Rep. 2012;14:476–83.CrossRefGoogle Scholar
  4. 4.
    Lee R, Margaritis M, Channon KM, Antoniades C. Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations. Curr Med Chem. 2012;19:2504–20.CrossRefGoogle Scholar
  5. 5.
    West AP, Brodsky IE, Rahner C, Woo DK, Erdjument-Bromage H, Tempst P, et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature. 2011;472:476–80.CrossRefGoogle Scholar
  6. 6.
    Stephens JW, Khanolkar MP, Bain SC. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis. 2009;202:321–9.CrossRefGoogle Scholar
  7. 7.
    Kotani K, Sakane N. C-reactive protein and reactive oxygen metabolites in subjects with metabolic syndrome. J Int Med Res. 2012;40:1074–81.CrossRefGoogle Scholar
  8. 8.
    Marrocco I, Altieri F, Peluso I. Measurement and clinical significance of biomarkers of oxidative stress in humans. Oxid Med Cell Longev. 2017;2017:6501046.CrossRefGoogle Scholar
  9. 9.
    Schöttker B, Brenner H, Jansen EH, Gardiner J, Peasey A, Kubinova R, et al. Evidence for the free radical/oxidative stress theory of ageing from the CHANCES consortium: a meta-analysis of individual participant data. BMC Med. 2015;13:300.CrossRefGoogle Scholar
  10. 10.
    Shao B, Heinecke JW. HDL, lipid peroxidation, and atherosclerosis. J Lipid Res. 2009;50:599–601.CrossRefGoogle Scholar
  11. 11.
    Li C, Zhang WJ, Choi J, Frei B. Quercetin affects glutathione levels and redox ratio in human aortic endothelial cells not through oxidation but formation and cellular export of quercetin-glutathione conjugates and upregulation of glutamate-cysteine ligase. Redox Biol. 2016;9:220–8.CrossRefGoogle Scholar
  12. 12.
    Masaki N, Sato A, Horii S, Kimura T, Toya T, Yasuda R, et al. Usefulness of the d-ROMs test for prediction of cardiovascular events. Int J Cardiol. 2016;222:226–32.CrossRefGoogle Scholar
  13. 13.
    Peasey A, Bobak M, Kubinova R, Malyutina S, Pajak A, Tamosiunas A, et al. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC Public Health. 2006;6:255.CrossRefGoogle Scholar
  14. 14.
    Schöttker B, Saum KU, Jansen EH, Boffetta P, Trichopoulou A, Holleczek B, et al. Oxidative stress markers and all-cause mortality at older age: a population-based cohort study. J Gerontol A Biol Sci Med Sci. 2015;70:518–24.CrossRefGoogle Scholar
  15. 15.
    Schöttker B, Haug U, Schomburg L, Köhrle J, Perna L, Müller H, et al. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr. 2013;97:782–93.CrossRefGoogle Scholar
  16. 16.
    Boffetta P, Bobak M, Borsch-Supan A, Brenner H, Eriksson S, Grodstein F, et al. The Consortium on Health and Ageing: network of Cohorts in Europe and the United States (CHANCES) project—design, population and data harmonization of a large-scale, international study. Eur J Epidemiol. 2014;29:929–36.CrossRefGoogle Scholar
  17. 17.
    Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010;29:1037–57.Google Scholar
  18. 18.
    Jansen E, Beekhof PK, Cremers JWJM, Viezeliene D, Muzakova V, Skalicky J. Short-term stability of biomarkers of oxidative stress and antioxidant status in human serum. ISRN Biomark. 2013;2013:5.CrossRefGoogle Scholar
  19. 19.
    Verde V, Fogliano V, Ritieni A, Maiani G, Morisco F, Caporaso N. Use of N,N-dimethyl-p-phenylenediamine to evaluate the oxidative status of human plasma. Free Radic Res. 2002;36:869–73.CrossRefGoogle Scholar
  20. 20.
    Jansen E, Beekhof PK, Viezeliene D, Muzakova V, Skalicky J. Long-term stability of oxidative stress biomarkers in human serum. Free Radic Res. 2017;51:970–7.CrossRefGoogle Scholar
  21. 21.
    Vassalle C, Bianchi S, Bianchi F, Landi P, Battaglia D, Carpeggiani C. Oxidative stress as a predictor of cardiovascular events in coronary artery disease patients. Clin Chem Lab Med. 2012;50:1463–8.CrossRefGoogle Scholar
  22. 22.
    Hirata Y, Yamamoto E, Tokitsu T, Kusaka H, Fujisue K, Kurokawa H, et al. Reactive oxygen metabolites are closely associated with the diagnosis and prognosis of coronary artery disease. J Am Heart Assoc. 2015;4:e001451.CrossRefGoogle Scholar
  23. 23.
    Hirata Y, Yamamoto E, Tokitsu T, Fujisue K, Kurokawa H, Sugamura K, et al. The pivotal role of a novel biomarker of reactive oxygen species in chronic kidney disease. Medicine (Baltimore). 2015;94:e1040.CrossRefGoogle Scholar
  24. 24.
    Xuan Y, Gao X, Holleczek B, Brenner H, Schöttker B. Prediction of myocardial infarction, stroke and cardiovascular mortality with urinary biomarkers of oxidative stress: Results from a large cohort study. Int J Cardiol. 2018 [epub ahead of print].  https://doi.org/10.1016/j.ijcard.2018.08.002.
  25. 25.
    Vassalle C, Botto N, Andreassi MG, Berti S, Biagini A. Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease. Coron Artery Dis. 2003;14:213–8.Google Scholar
  26. 26.
    Vassalle C, Petrozzi L, Botto N, Andreassi MG, Zucchelli GC. Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J Intern Med. 2004;256:308–15.CrossRefGoogle Scholar
  27. 27.
    Elesber AA, Best PJ, Lennon RJ, Mathew V, Rihal CS, Lerman LO, et al. Plasma 8-iso-prostaglandin F2alpha, a marker of oxidative stress, is increased in patients with acute myocardial infarction. Free Radic Res. 2006;40:385–91.CrossRefGoogle Scholar
  28. 28.
    Steinberg D. The LDL modification hypothesis of atherogenesis: an update. J Lipid Res. 2009;50(Suppl):S376–81.CrossRefGoogle Scholar
  29. 29.
    Gargiulo S, Testa G, Gamba P, Staurenghi E, Poli G, Leonarduzzi G. Oxysterols and 4-hydroxy-2-nonenal contribute to atherosclerotic plaque destabilization. Free Radic Biol Med. 2017;111:140–50.CrossRefGoogle Scholar
  30. 30.
    Hoseini Z, Sepahvand F, Rashidi B, Sahebkar A, Masoudifar A, Mirzaei H. NLRP3 inflammasome: its regulation and involvement in atherosclerosis. J Cell Physiol. 2018;233:2116–32.CrossRefGoogle Scholar
  31. 31.
    Kameda K, Matsunaga T, Abe N, Hanada H, Ishizaka H, Ono H, et al. Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease. Possible role for left ventricular remodelling. Eur Heart J. 2003;24:2180–5.CrossRefGoogle Scholar
  32. 32.
    Icme F, Erel O, Avci A, Satar S, Gulen M, Acehan S. The relation between oxidative stress parameters, ischemic stroke, and hemorrhagic stroke. Turk J Med Sci. 2015;45:947–53.CrossRefGoogle Scholar
  33. 33.
    Cherubini A, Ruggiero C, Polidori MC, Mecocci P. Potential markers of oxidative stress in stroke. Free Radic Biol Med. 2005;39:841–52.CrossRefGoogle Scholar
  34. 34.
    Saeed SA, Shad KF, Saleem T, Javed F, Khan MU. Some new prospects in the understanding of the molecular basis of the pathogenesis of stroke. Exp Brain Res. 2007;182:1–10.CrossRefGoogle Scholar
  35. 35.
    Duan X, Wen Z, Shen H, Shen M, Chen G. Intracerebral hemorrhage, oxidative stress, and antioxidant therapy. Oxid Med Cell Longev. 2016;2016:1203285.CrossRefGoogle Scholar
  36. 36.
    Pandey KB, Mehdi MM, Maurya PK, Rizvi SI. Plasma protein oxidation and its correlation with antioxidant potential during human aging. Dis Markers. 2010;29:31–6.CrossRefGoogle Scholar
  37. 37.
    Vassalle C, Sciarrino R, Bianchi S, Battaglia D, Mercuri A, Maffei S. Sex-related differences in association of oxidative stress status with coronary artery disease. Fertil Steril. 2012;97:414–9.CrossRefGoogle Scholar
  38. 38.
    Dantas AP, Franco MC, Silva-Antonialli MM, Tostes RC, Fortes ZB, Nigro D, et al. Gender differences in superoxide generation in microvessels of hypertensive rats: role of NAD(P)H-oxidase. Cardiovasc Res. 2004;61:22–9.CrossRefGoogle Scholar
  39. 39.
    Bhatia K, Elmarakby AA, El-Remessy AB, Sullivan JC. Oxidative stress contributes to sex differences in angiotensin II-mediated hypertension in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2012;302:R274–82.CrossRefGoogle Scholar
  40. 40.
    Nickelson KJ, Stromsdorfer KL, Pickering RT, Liu TW, Ortinau LC, Keating AF, et al. A comparison of inflammatory and oxidative stress markers in adipose tissue from weight-matched obese male and female mice. Exp Diabetes Res. 2012;2012:859395.CrossRefGoogle Scholar
  41. 41.
    Fernandez-Sanchez A, Madrigal-Santillan E, Bautista M, Esquivel-Soto J, Morales-Gonzalez A, Esquivel-Chirino C, et al. Inflammation, oxidative stress, and obesity. Int J Mol Sci. 2011;12:3117–32.CrossRefGoogle Scholar
  42. 42.
    Fonseca-Alaniz MH, Takada J, Alonso-Vale MI, Lima FB. Adipose tissue as an endocrine organ: from theory to practice. J Pediatr (Rio J). 2007;83:S192–203.CrossRefGoogle Scholar
  43. 43.
    Pugliese G, Solini A, Bonora E, Orsi E, Zerbini G, Giorgino F, et al. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetes. Atherosclerosis. 2011;218:194–9.CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2018

Authors and Affiliations

  • Yang Xuan
    • 1
    • 2
  • Martin Bobak
    • 3
  • Ankita Anusruti
    • 1
    • 2
  • Eugène H. J. M. Jansen
    • 4
  • Andrzej Pająk
    • 5
  • Abdonas Tamosiunas
    • 6
  • Kai-Uwe Saum
    • 1
  • Bernd Holleczek
    • 7
  • Xin Gao
    • 1
    • 2
  • Hermann Brenner
    • 1
    • 2
  • Ben Schöttker
    • 1
    • 2
    • 8
    Email author
  1. 1.Division of Clinical Epidemiology and Ageing ResearchGerman Cancer Research CenterHeidelbergGermany
  2. 2.Network Aging ResearchUniversity of HeidelbergHeidelbergGermany
  3. 3.Department Epidemiology and Public HealthUniversity College LondonLondonUK
  4. 4.Centre for Health ProtectionNational Institute for Public Health and the EnvironmentBilthovenThe Netherlands
  5. 5.Faculty of Health SciencesJagiellonian University Medical CollegeKrakówPoland
  6. 6.Institute of Cardiology of LithuanianUniversity of Health SciencesKaunasLithuania
  7. 7.Saarland Cancer RegistrySaarbrückenGermany
  8. 8.Institute of Health Care and Social SciencesFOM UniversityEssenGermany

Personalised recommendations